Clinical trials: Social Media Addiction

Smoking Cessation

Twitter-enabled Mobile Messaging for Smoking Relapse Prevention (Tweet2Quit)

• Completed
• Age: 21 to 59 years
• Phase 2
• Lifestyle or therapy programme
• Results posted

Tweet2Quit is an innovative smoking cessation intervention that combines real-time online peer-to-peer support with auto messaging.

Trial name

Tweet2Quit (NCT02823028)

Testing

NRT, Web Guide, Tweet2Quit

Where

2 sites in United States

Volunteers

980 people, healthy volunteers welcome

Sponsor

University of California, Irvine